Trial of Therapeutic Hypothermia in Patients With ARDS
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jeffrey D Hasday, MD
University of Maryland, Baltimore
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Yale University
New Haven, Connecticut, United States
- Emory University
Atlanta, Georgia, United States
- Loyola University Chicago
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Kentucky
Lexington, Kentucky, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Cooper Health System
Camden, New Jersey, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Cleveland Clinc
Cleveland, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Temple University
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- University of Pennsylavia
Philadelphia, Pennsylvania, United States
- Brooke Army Medical Center
Fort Sam Houston, Texas, United States
- Intermountain Healthcare (utah)
Salt Lake City, Utah, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jun 2021
- Primary completion
- 30 Jun 2026
- Completion
- 30 Sept 2026
- Last update posted
- 9 Sept 2026
- Registered enrollment
- 340
- Registry id
- NCT04545424
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.